Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon

Journal of Gene Medicine

Volumn 11, Issue 11, 2009, Pages 1030-1038

  Pan, Yongfei ^a   Zhao, Qian ^a   Fang, Liurong ^a   Luo, Rui ^a   Chen, Huanchun ^a   Xiao, Shaobo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Apoptosis; Baculovirus; Gene delivery; Mammalian cell; Replicon; Semliki Forest virus

Indexed keywords

BACULOVIRUS VECTOR; CASPASE 3; DNA; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPLICON; REPORTER GENE; SEMLIKI FOREST ALPHAVIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS HYBRID; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYTOMEGALOVIRUS; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; PROMOTER REGIONS, GENETIC; REPLICON; SEMLIKI FOREST VIRUS; TRANSDUCTION, GENETIC; TRANSFECTION;

ALPHAVIRUS; CYTOMEGALOVIRUS; HEXAPODA; MAMMALIA; SEMLIKI FOREST VIRUS;

EID: 72949109385     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1390     Document Type: Article

References (38)

1. Miller LK. Baculoviruses for foreign gene expression in insect cells. Biotechnology 1988; 10: 457-465.
2. Cory JS, Bishop DH. Use of baculoviruses as biological insecticides. Mol Biotechnol 1997; 7: 303-313.
3. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099-10103.
4. Boyce FM, Butcher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-2352.
5. Shoji I, Aizaki H, Tani H, et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 1997; 78: 2657-2664.
6. Liu YK, Chu CC, Wu TY. Baculovirus ETL promoter acts as a shuttle promoter between insect cells and mammalian cells. Acta Pharmacol Sin 2006; 27: 321-327.
7. Lu L, Yu L, Kwang J. Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 2007; 358: 404-409.
8. GaoH, WangY, LiN, et al. Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells. J Biotechnol 2007; 131: 138-143.
9. Hu YC. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005; 26: 405-416.
10. Strauss R, Hüser A, Ni S, et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007; 15: 193-202.
11. Kost TA, Condreay JP, Jarvis D. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23: 567-575. DOI: 10.1038/nbt1095.
12. Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 2005; 6: 5-11.
13. Shan L, Wang L, Yin J, Zhong P, Zhong J. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression. J Gene Med 2006; 8: 1400-1406.
14. Lundstrom K. Alphavirus vectors for vaccine production and gene therapy. Expert Rev Vaccines 2003; 2: 447-459.
15. Kohno A, Emi N, Kasai M, Tanimoto M, Saito H. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Ther 1998; 5: 415-418.
16. DiCiommo DP, Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 1998; 273: 18060-18066.
17. Liang CY, Wang HZ, Li TX, Hu ZH, Chen XW. High efficiency gene transfer into mammalian kidney cells using baculovirus vectors. Arch Virol 2004; 149: 51-60.
18. Fan H, Pan Y, Fang L, et al. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 2008; 150: 21-26.
19. Hsu CS, Ho YC, Wang KC, Hu YC. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 2004; 88: 42-51.
20. Condreay JP,Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127-132.
21. Kerr FR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In Apoptosis: The Molecular Basis of Cell Death, Tomei LD, Cope FO (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor NY, 1991; 5-29.
22. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907.
23. Leitner WW, Ying H, Restifo NP. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999; 18: 765-777.
24. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
25. Leitner WW, Hwang LN, Bergmann-Leitner ES, Finkelstein SE, Frank S, Restifo NP. Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine 2004; 22: 1537-1544.
26. Ljungberg K, Whitmore AC, Fluet ME, et al. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J Virol 2007; 81: 13412-13423.
27. Nordström EK, Forsell MN, Barnfield C, et al. Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J Gen Virol 2005; 86: 349-354.
28. Scheiblhofer S, Weiss R, Gabler M, Leitner WW, Thalhamer J. Replicase-based DNA vaccines for allergy treatment. Methods Mol Med 2006; 127: 221-235.
29. Martyn JC, Dong X, Holmes-Brown S, et al. Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus. Arch Virol 2007; 152: 329-343.
30. Abe T, Hemmi H, Miyamoto H, et al. Involvement of the Tolllike receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005; 79: 2847-2858.
31. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003; 171: 1133-1139.
32. Facciabene A, Aurisicchio L, La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004; 78: 8663-8672.
33. Gronowski AM, Hilbert DM, Sheehan KC, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999; 73: 9944-9951.
34. Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljestrom P. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 1994; 12: 1510-1514.
35. Tani H, Limn CK, Yap CC, et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003; 77: 9799-9808.
36. Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 1997; 8: 2011-2018.
37. Sandig V, Hofmann C, Steinert S. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 1996; 7: 1937-1945.
38. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 2001; 12: 871-881.